Drug treatment of tuberculosis meningitis in children. A practical guide

CNS Drugs

Volumn 6, Issue 1, 1996, Pages 12-22

  Donald, Peter R ^a,b   Parkin, Donald P ^a   Seifart, Heiner I ^a   Schoeman, Johan F ^a   Van Zyl, Lana E ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; FUROSEMIDE; ISONIAZID; OFLOXACIN; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

CHILD; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TUBERCULOUS MENINGITIS;

EID: 0029937259     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199606010-00002     Document Type: Review

References (56)

1. Bishburg E, Sunderam G, Reichman LB, et al. Central nervous system tuberculosis with the acquired immuno-deficiency syndrome and its related complex. Ann Intern Med 1986; 105: 201-13
2. Berman S, Kibel MA, Fourie PB, et al. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa. Tuber Lung Dis 1992; 73: 349-55
3. Naughten E, Newton R, Weindling AM, et al. Tuberculous meningitis in children. Recent experience in two English Centres. Lancet 1981; II: 973-5
4. Lincoln EM, Sewell EM. Tuberculosis of the meninges and central nervous system. In: Tuberculosis in children. New York: McGraw-Hill, 1963: 161-83
5. Rich AR, McCordock HH. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp 1993; 52: 5-37
6. Schoeman JF, van Zyl LE, Laubscher JA, et al. Serial CT scanning in childhood tuberculous meningitis. Prognostic features in 198 cases. J Child Neurol 1995; 10: 320-9
7. Rook GAW, Folwy NM, Meager A. What mediates the immunopathological component of the immune response to Mycobacterium tuberculosis? Can it be switched off? Bull Int Union Tuber Lung Dis 1990; 65: 23-6
8. Iseman MD, Sbarbaro JA. Short course chemotherapy of tuberculosis. Am Rev Respir Dis 1991; 143: 697-8
9. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide. Am Rev Respir Dis 1991; 143: 700-6
10. Mitchison DA. The action of antituberculosis drugs in short course chemotherapy. Tubercle 1985; 66: 219-25
11. Jindani A, Aber VR, Edwards EA, et al. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-49
12. Botha F, Sirgel FA, Parkin DP, et al. The early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S Afr Med J 1996; 86: 155-8
13. Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med 1980; 1: 231-41
14. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-74
15. World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. Geneva: World Health Organization, 1993
16. Scheld WM. Theoretical and practical considerations of antibiotic therapy for bacterial meningitis. Pediatr Infect Dis 1985; 4: 74-83
17. Donald PR, Gent WL, Seifart HI, et al. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status. Pediatrics 1992; 89: 247-50
18. Ramachandran M, Duraipandian M, Nagarajan M, et al. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986; 67: 17-29
19. Phuapradit P, Vejjajiva A. Treatment of tuberculous meningitis: role of short course chemotherapy. Q J Med 1987; 239: 249-58
20. Alarcon F, Escalate L, Perez Y, et al. Tuberculous meningitis. Short course chemotherapy. Arch Neurol 1990; 47: 1313-7
21. Jacobs RF, Sunakorn P, Chotpitayasunonah T, et al. Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992; 11: 194-8
22. Moulding TS. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance? Am Rev Respir Dis 1981; 123: 262-4
23. Elliott AM, Berning SE, Iseman MD, et al. Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuber Lung Dis 1995; 76: 463-7
24. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993; 148: 650-5
25. Long MW, Snider DE, Farer LS. US Public Health Service cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119: 879-94
26. Sirgel FA, Botha FJH, Parkin DP, et al. The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment. J Antimicrob Chemother 1993; 32: 867-75
27. Ellard GA, Humphries, MJ, Gabriel M, et al. The penetration of pyrazinamide into the cerebrospinal fluid in patients with tuberculous meningitis. BMJ 1987; 294: 284-5
28. Donald PR, Seifart HI. Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis. Pediatr Infect Dis J 1988; 7: 469-71
29. Hughes IE, Smith HV, Kane PO. Ethionamide and its passage into the cerebrospinal fluid in man. Lancet 1962; I: 616-7
30. Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr 1989; 115: 483-6
31. Gundert-Remy U, Klett M, Weber E. Concentration of ethambutol in cerebrospinal fluid in man as a function of non-protein-bound fraction in serum. J Clin Pharmacol 1964; 6: 133-6
32. Bobrowitz ID. Ethambutol in tuberculous meningitis. Chest 1972; 61: 629-32
33. Humphries MJ, Teoh R, Lau J, et al. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990; 71: 161-8
34. Chotmongkol V. Treatment of tuberculous meningitis with 6-month course of chemotherapy. Southeast Asian J Trop Med Public Health 1991; 22: 372-4
35. Biddulph J. Short course chemotherapy for childhood tuberculosis. Pediatr Infect Dis J 1990; 9: 794-801
36. Rahajoe NN, Rahajoe N, Boediman I, et al. The treatment of tuberculous meningitis in children with a combination of isoniazid, rifampicin and streptomycin: preliminary report. Tubercle 1979; 60: 245-50
37. Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioti S, et al. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampicin. Pediatr Infect Dis 1985; 4: 270-3
38. Donald PR, Schoeman JF, O'Kennedy A. Hepatic toxicity during chemotherapy for severe tuberculous meningitis. Am J Dis Child 1987; 141: 741-3
39. Kumar A, Misra PK, Mehotra R, et al. Hepatotoxicity of rifampin and isoniazid : is it all drug-induced hepatitis? Am Rev Respir Dis 1991; 143: 1350-2
40. Türktas H, Ünsal M, Tülek N, et al. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis. Tuber Lung Dis 1994; 75: 58-60
41. Schoeman JF, le Roux D, Bezuidenhout PB, et al. Intracranial pressure monitoring in tuberculous meningitis: clinical and computerized tomographic correlation. Dev Med Child Neurol 1985; 27: 644-54
42. Schoeman J, Donald P, van Zyl L, et al. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol 1991; 33: 396-405
43. Cotton MF, Donald PR, Schoeman JF, et al. Plasma arginine vasopressin and the syndrome of inappropriate antidiuretic hormone secretion in tuberculous meningitis. Pediatr Infect Dis J 1991; 10: 837-42
44. Gordon A, Parsons M. The place of corticosteroids in the management of tuberculous meningitis. Br J Hosp Med 1972; 7: 651-5
45. Horne NW. A critical evaluation of corticosteroids in tuberculosis. Adv Tuberc Res 1966; 15: 1-54
46. Freiman I, Geefhuysen J. Evaluation of intrathecal therapy with streptomycin and hydrocortisone in tuberculous meningitis. J Pediatr 1970; 76: 895-901
47. Escobar JA, Belsey MA, Duenas A, et al. Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics 1975; 56: 1050-5
48. Shao PP, Wang SM, Tung SC. Clinical analysis of 445 adult cases of tuberculous meningitis. Chin J Tuber Respir Dis 1980; 3: 131-2
49. Girgis NI, Farid Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991; 10: 179-83
50. Humphries M. The management of tuberculous meningitis. Thorax 1992; 47: 577-81
51. Berger JR. Tuberculous meningitis. Editorial review. Curr Opin Neurol 1994; 7: 191-200
52. Baciewicz AM, Self TH, Bekemeyer WB. Update on rifampin drug interactions. Arch Intern Med 1987; 147: 565-8
53. Schoeman JF, van Zyl LE, Laubscher JA, et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings and clinical outcome in young children with tuberculous meningitis. Pediatrics. In press
54. Donald PR, Schoeman JF, Beyers N, et al. Concentrations of interferon γ, tumor necrosis factor α and interleukin 1β in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis 1995; 21: 924-9
55. Pulsinelli W. Pathophysiology of acute ischaemic stroke. Lancet 1992; 339: 533-9
56. Bobrowitz ID. Levels of rifampin in cerebrospinal fluid. Chest 1973; 63: 648-9